Menu
Search
|

Menu

Close
X

Hypera SA HYPE3.SA (Sao Paulo Stock Exchange)

32.60 BRL
-0.19 (-0.58%)
As of Sep 13
Previous Close 32.79
Open 32.89
Volume 614,600
3m Avg Volume 1,938,620
Today’s High 32.96
Today’s Low 32.41
52 Week High 33.93
52 Week Low 24.56
Shares Outstanding (mil) 632.24
Market Capitalization (mil) 21,439.19
Forward P/E 24.65
Dividend (Yield %) 1.30 ( 3.28 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.38 Mean rating from 16 analysts

KEY STATS

Revenue (mm, BRL)
FY19
1,357
FY18
3,724
FY17
3,500
FY16
3,228
EPS (BRL)
FY19
1.043
FY18
1.772
FY17
1.558
FY16
1.020
*Note: Units in Millions of Real
**Note: Units in Real

KEY RATIOS

Price to Earnings (TTM)
vs sector
24.65
32.66
Price to Sales (TTM)
vs sector
6.24
7.91
Price to Book (MRQ)
vs sector
2.73
5.38
Price to Cash Flow (TTM)
vs sector
22.60
24.36
Total Debt to Equity (MRQ)
vs sector
8.46
14.55
LT Debt to Equity (MRQ)
vs sector
4.05
10.20
Return on Investment (TTM)
vs sector
8.83
14.48
Return on Equity (TTM)
vs sector
10.30
15.78

EXECUTIVE LEADERSHIP

Luiz Eduardo Violland
Chairman of the Board, Since 2017
Salary: --
Bonus: --
Claudio Bergamo dos Santos
Chief Executive Officer, Member of the Executive Board, Since 2017
Salary: --
Bonus: --
Martim Prado Mattos
Chief Financial Officer, Chief Controllership Officer, Member of the Executive Board, Since 2014
Salary: --
Bonus: --
Vivian Karina Trujillo Angiolucci
Chief Operating Officer, Member of the Executive Board, Since 2016
Salary: --
Bonus: --
Breno Toledo Pires de Oliveira
Investor Relations Officer, Member of the Executive Board, Since 2011
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

R Nova Cidade. 404
SAO PAULO     04.547-070

Phone: +5511.36274200

Hypera SA, formerly Hypermarcas SA, is a Brazil-based company engaged in the pharmaceuticals sector. The Company’s major business units include Branded Prescription, Consumer Health and Branded Generics. Branded Prescription is present in the main therapeutic classes in Brazil and it operates in the Primary Care segment under the umbrella brand Mantecorp Farmasa. The Branded Prescription unit also acts as Mantecorp Skincare in dermocosmetics, with products recommended by dermatologists. Consumer Health offers non-prescription drugs, with brands such as Apracur, Benegrip, Coristina d, Engov, Epocler and Estomazil, among others. The Consumer Health unit also operates in nutritionals and vitamin supplements, with brands such as Tamarine, Vitasay, Biotonico Fontoura and Zero-Cal. Branded Generics operates under the Neo Quimica brand.

SPONSORED STORIES